ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2016
[M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis and Adhesion in Small Cell Lung Cancer].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveStudies have shown that muscarinic receptors 3 (M3R) plays key roles in regulating tumorigenesis and tumor growth. The aim of this study is to investigate the expression of M3R in human small cell lung cancer (SCLC) cell line SBC3 and to explore the effect of M3R antagonist on cell proliferation, apoptosis and adhesion.
methodsSBC3 cells were cultured in vitro. RT-PCR and Western blot were used to detect the expression of M3R in SBC-3. MTT assay and flow cytometry were used to determine the effects of M3R antagonist 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) on the proliferation and apoptosis of SBC-3 cells. Flow cytometry was used to detect the integrin expression in SBC3 and alteration of integrin expression after treating the cells with cholinergic receptor agonist acetylcholine iodide (acetylcholine iodide, Ach) and 4-DAMP. Fibronectin (Fn) coated 96-well plates were used to detect the effect of Ach, 4-DAMP and anti-integrin antibody on cell adhesion.
resultsM3R was expressed in SBC3 cells. 4-DAMP significantly inhibited SBC3 cells proliferation in a dose-dependent manner. 4-DAMP promoted cell apoptosis at a concentration of 10-4 M of 4-DAMP compared with control. αvβ1 and α5β1 integrin were expressed in SBC3 cells. 10-4 M Ach stimulated cell adhesion toward Fn significantly (P<0.01). This effect was completely abrogated by 10-5 M 4-DAMP, 5 μg/mL anti-β1 integrin antibody or anti-αv and anti-α5 integrin antibodies (P<0.01) and partially abrogated by 5 μg/mL anti-αv or anti-α5 integrin antibody (P<0.05). But Ach and 4-DAMP did not alter Fn receptor (αvβ1 or α5β1 integrin) expression.
conclusionM3R is expressed in SBC3 cell. The M3R antagonist inhibits SBC3 cell proliferation, adhesion and enhances cell apoptosis. M3R antagonist inhibiting SBC3 cell adhesion is presumably modulated by functional alteration of β1 containing integrins (αvβ1 and α5β1), but not by any variation in their expression. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.